GNI Group Ltd. (2160.T)
JPY 2227.0
(12.36%)
JPY 2227.0
(12.36%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 13.1 Billion JPY | 232.42% |
| 2022 | 1.37 Billion JPY | -15.2% |
| 2021 | 1.62 Billion JPY | -13.08% |
| 2020 | 1.86 Billion JPY | 43.55% |
| 2019 | 1.3 Billion JPY | 129.05% |
| 2018 | 568.6 Million JPY | 268.71% |
| 2017 | 154.21 Million JPY | 155.8% |
| 2016 | -276.36 Million JPY | 56.35% |
| 2015 | -633.16 Million JPY | -14.98% |
| 2014 | -550.67 Million JPY | 29.86% |
| 2013 | -785.14 Million JPY | -69.01% |
| 2012 | -464.56 Million JPY | -1.59% |
| 2011 | -457.29 Million JPY | -69.98% |
| 2010 | -269.02 Million JPY | 0.0% |
| 2008 | -949.43 Million JPY | 26.12% |
| 2007 | -1.28 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 277.08 Million JPY | -63.26% |
| 2024 Q1 | 754.2 Million JPY | 133.3% |
| 2023 Q2 | 5.07 Billion JPY | 2807.78% |
| 2023 Q3 | 1.32 Billion JPY | -73.89% |
| 2023 FY | 4.58 Billion JPY | 232.42% |
| 2023 Q1 | 174.66 Million JPY | 250.24% |
| 2023 Q4 | -2.26 Billion JPY | -270.8% |
| 2022 Q1 | 478.92 Million JPY | 242.74% |
| 2022 Q3 | 661.5 Million JPY | 25.82% |
| 2022 Q4 | -116.25 Million JPY | -117.57% |
| 2022 FY | 1.37 Billion JPY | -15.2% |
| 2022 Q2 | 525.74 Million JPY | 9.77% |
| 2021 Q3 | 504.83 Million JPY | -25.98% |
| 2021 Q1 | 773.57 Million JPY | 69.05% |
| 2021 Q2 | 682.05 Million JPY | -11.83% |
| 2021 FY | 1.62 Billion JPY | -13.08% |
| 2021 Q4 | -335.51 Million JPY | -166.46% |
| 2020 Q1 | 416.46 Million JPY | 88.31% |
| 2020 Q2 | 445.25 Million JPY | 6.91% |
| 2020 Q3 | 550.21 Million JPY | 23.57% |
| 2020 Q4 | 457.59 Million JPY | -16.83% |
| 2020 FY | 1.86 Billion JPY | 43.55% |
| 2019 Q3 | 399.74 Million JPY | -7.13% |
| 2019 Q1 | 251 Million JPY | 69.05% |
| 2019 FY | 1.3 Billion JPY | 129.05% |
| 2019 Q2 | 430.44 Million JPY | 71.49% |
| 2019 Q4 | 221.15 Million JPY | -44.67% |
| 2018 Q2 | 133.43 Million JPY | 25.73% |
| 2018 Q3 | 180.55 Million JPY | 35.31% |
| 2018 Q1 | 106.12 Million JPY | -61.08% |
| 2018 FY | 568.6 Million JPY | 268.71% |
| 2018 Q4 | 148.48 Million JPY | -17.76% |
| 2017 Q1 | -76.11 Million JPY | -1890.98% |
| 2017 FY | 154.21 Million JPY | 155.8% |
| 2017 Q3 | 25.88 Million JPY | 137.94% |
| 2017 Q2 | -68.23 Million JPY | 10.36% |
| 2017 Q4 | 272.67 Million JPY | 953.28% |
| 2016 Q1 | -108 Million JPY | 53.62% |
| 2016 Q2 | -120.95 Million JPY | -11.99% |
| 2016 FY | -276.36 Million JPY | 56.35% |
| 2016 Q4 | -3.82 Million JPY | 91.23% |
| 2016 Q3 | -43.58 Million JPY | 63.97% |
| 2015 FY | -633.16 Million JPY | -14.98% |
| 2015 Q2 | -126.51 Million JPY | -6.89% |
| 2015 Q1 | -118.35 Million JPY | -2.23% |
| 2015 Q4 | -232.85 Million JPY | -46.47% |
| 2015 Q3 | -158.97 Million JPY | -25.65% |
| 2014 Q3 | -140.54 Million JPY | 0.18% |
| 2014 FY | -550.67 Million JPY | 29.86% |
| 2014 Q4 | -115.77 Million JPY | 17.63% |
| 2014 Q1 | -153.55 Million JPY | 18.38% |
| 2014 Q2 | -140.8 Million JPY | 8.31% |
| 2013 FY | -785.14 Million JPY | -69.01% |
| 2013 Q4 | -188.12 Million JPY | 50.25% |
| 2013 Q1 | -113.15 Million JPY | 1.53% |
| 2013 Q2 | -105.73 Million JPY | 6.56% |
| 2013 Q3 | -378.13 Million JPY | -257.64% |
| 2012 Q1 | -124.2 Million JPY | 8.42% |
| 2012 Q4 | -114.91 Million JPY | 1.95% |
| 2012 Q3 | -117.2 Million JPY | -8.28% |
| 2012 FY | -464.56 Million JPY | -1.59% |
| 2012 Q2 | -108.24 Million JPY | 12.85% |
| 2011 Q1 | -126.27 Million JPY | -827.16% |
| 2011 Q3 | -93.69 Million JPY | 9.1% |
| 2011 FY | -457.29 Million JPY | -69.98% |
| 2011 Q4 | -135.62 Million JPY | -44.75% |
| 2011 Q2 | -103.07 Million JPY | 18.37% |
| 2010 Q1 | -135.42 Million JPY | 0.0% |
| 2010 FY | -269.02 Million JPY | 0.0% |
| 2010 Q4 | -13.61 Million JPY | -97.12% |
| 2010 Q3 | -6.9 Million JPY | 93.89% |
| 2010 Q2 | -113.06 Million JPY | 16.51% |
| 2009 Q3 | -153.04 Million JPY | -1.55% |
| 2009 Q1 | -142.59 Million JPY | 30.87% |
| 2009 Q2 | -150.71 Million JPY | -5.7% |
| 2008 FY | -949.43 Million JPY | 26.12% |
| 2008 Q4 | -206.25 Million JPY | 30.25% |
| 2008 Q3 | -295.7 Million JPY | 5.53% |
| 2008 Q2 | -313 Million JPY | 0.0% |
| 2007 FY | -1.28 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | -2096.441% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | 2738.295% |
| Linical Co., Ltd. | 725.72 Million JPY | -1706.312% |
| Trans Genic Inc. | 89.43 Million JPY | -14557.233% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 1019.305% |
| Soiken Holdings Inc. | -610 Million JPY | 2248.966% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | 1796.406% |
| AnGes, Inc. | -11.96 Billion JPY | 209.537% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 1269.598% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 237.611% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | -12468.522% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | 1616.499% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 1273.599% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 1138.736% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | 1741.564% |
| RaQualia Pharma Inc. | -337.36 Million JPY | 3985.656% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 1187.719% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 1081.497% |
| PeptiDream Inc. | 6.77 Billion JPY | -93.544% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 779.22% |
| Ribomic Inc. | -1.11 Billion JPY | 1274.424% |
| SanBio Company Limited | -4.53 Billion JPY | 388.805% |
| Healios K.K. | -3.37 Billion JPY | 487.95% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 1234.887% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 1040.706% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 1034.344% |
| StemRIM | -2.07 Billion JPY | 731.447% |
| CellSource Co., Ltd. | 1.22 Billion JPY | -973.177% |
| FunPep Company Limited | -994 Million JPY | 1418.797% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 1574.955% |
| Stella Pharma Corporation | -760.3 Million JPY | 1824.167% |
| TMS Co., Ltd. | -943.25 Million JPY | 1489.748% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 1790.611% |
| Cuorips Inc. | -588.48 Million JPY | 2327.55% |
| K Pharma,Inc. | 366.05 Million JPY | -3481.093% |
| Takara Bio Inc. | 3 Billion JPY | -336.525% |
| ReproCELL Incorporated | -409.29 Million JPY | 3302.802% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | -118392.66% |
| StemCell Institute Inc. | 413.75 Million JPY | -3068.232% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | -8971.424% |
| CellSeed Inc. | -697.77 Million JPY | 1978.661% |